New insights that APOE4 homozygosity represents a distinct genetic form of AD reinforce the clinical value of routine APOE genotyping not only for risk stratification but also for aligning individuals, particularly APOE4 homozygotes, with personalized monitoring and intervention strategies reflective of their genetically driven disease trajectory. Here, APOE is linked to Alzheimer disease.